25/08/2016 23:19:45 1-888-992-3836 (toll free) Free Membership Login

Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
08/15/20169:00AMBWPAREXEL’s Head of BioPharm Unit Named to the 2016 PharmaVOICE 100
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that PharmaVOICE magazine selected Ubavka DeNoble, MD, Corporate Vice President, as one of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2016 issue... More...>>
08/03/20164:27PMBWPAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
Fourth Quarter Fiscal Year 2016 Results (compared to Fourth Quarter Fiscal Year 2015) GAAP diluted earnings per share of $0.83, up 36.1%; adjusted earnings per share of $0.94, up 19.0% GAAP operating margin of 12.3%; adjusted operating margin of 13.7% Service revenue of $538.6 million, up 3.0%; constant currency revenue... More...>>
08/02/20163:03AMDJNQuick CFO Exits Can Spell Trouble -- WSJ
By Alix Stuart When 3D Systems Corp. announced it was "privileged" to be hiring Ted Hull as its new finance chief in November 2014, it seemed like a coup given his experience at companies including Cisco Systems Inc. and International Business Machines Corp. Six months after he joined, 3D Systems stock was down... More...>>
08/01/201612:49PMDJNA Quick CFO Exit Can Spell Trouble
By Alix Stuart When 3D Systems Corp. announced it was "privileged" to be hiring Ted Hull as its new finance chief in November 2014, it seemed like a coup given his experience at companies including Cisco Systems Inc. and International Business Machines Corp. Six months after he joined, 3D Systems stock was down... More...>>
08/01/20169:00AMBWPAREXEL Appoints Four Executives to Senior Leadership Team
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review Committee: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160801005138/en/... More...>>
07/11/20169:00AMBWPAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for Fourth Quarter and Fiscal Year 2016 on Wednesday, August 3, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, August 4, 2016, to discuss the results. To access the... More...>>
06/30/20168:00AMBWPAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day
10–18% diluted EPS growth expected in Fiscal Year 2017*, driven by continued revenue growth and margin improvement Long-term target range for adjusted operating margin increased to 14–16% Long-term target of double-digit revenue and adjusted diluted EPS growth PAREXEL’s growth strategy built on focus on its core... More...>>
06/20/20169:00AMBWPAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia. PAREXEL will hold in-booth... More...>>
06/15/20169:00AMBWPAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from 9:00 a.m. to 12:00 p.m. EDT. All interested parties are invited to listen as Chairman and Chief Executive... More...>>
06/10/20162:00AMBWPAREXEL Announces Master Services Agreement with Pfizer
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical... More...>>
06/02/20169:00AMBWPAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American Business Awards
Company also awarded Gold Stevie Award for Best Public Relations Event PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business AwardsSM. The judges awarded PAREXEL a Gold Stevie®... More...>>
05/24/20169:00AMBWPAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June. Ingo Bank, Senior Vice President and Chief Financial Officer, will present at the Goldman Sachs Global... More...>>
05/09/20169:00AMBWPAREXEL International to Present at UBS Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at 8:30 a.m... More...>>
04/27/20164:01PMBWPAREXEL International Reports Third Quarter Fiscal Year 2016 Results
Adjusted earnings per share of $0.89, up 34.8%; GAAP diluted earnings per share of $0.89, up 30.9% Adjusted operating margin of 13.3%; GAAP operating margin of 13.2% Gross new business wins of $999 million; net book-to-bill ratio of 1.33; backlog at $5.7 billion Service revenue of $527.1 million, up 5.0%; constant currency... More...>>
04/21/20162:00PMBWPAREXEL International to Present at Deutsche Bank Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will present at the Deutsche Bank 41st Annual Health Care Conference in Boston. Mr. Josef von Rickenbach, Chairman and CEO, will make a presentation on PAREXEL’s business activities and financial outlook at 12:50 p.m. Wednesday, May 4, 2016. A live... More...>>
04/13/20169:00AMBWPAREXEL and EMC Form Alliance to Provide Cloud-Based Document and Regulatory Information Management Services
PAREXEL enhances its Regulatory Cloud; leverages EMC® Documentum® for Life Sciences software solution suite to offer an end-to-end regulatory solution PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, and EMC Corporation (NYSE: EMC) today announced they have entered... More...>>
03/24/20164:00PMBWPAREXEL International Announces Date of Third Quarter Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2016 on Wednesday, April 27th, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, April 28th, 2016 to discuss the results. To access... More...>>
03/23/20162:40PMBWPAREXEL Named to the 2016 Forbes America’s Best Employers List
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that Forbes named the Company to the magazine’s America’s “Best Employers” list for 2016. The list features the top 500 U.S. employers with more than 5,000 employees as rated by 30,000 employees... More...>>
03/03/20169:00AMBWPAREXEL International to Present at Barclay’s Global Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Barclay’s Global Healthcare Conference on Thursday, March 17, 2016, in Miami. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at... More...>>
02/29/20169:00AMBWParexel Named a FlexJobs Top 100 Company to Watch for Telecommuting Jobs in 2016
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting Jobs in 2016 for the third consecutive year. The list recognizes companies with a telecommuting-friendly component... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V:us D:20160826 03:19:46